CLINICAL PHARMACOLOGY OF N-ACETYLPROCAINAMIDE (NAPA), MAJOR METABOLITE OF PROCAINAMIDE IN MAN

被引：0
作者：
KLUGER, J
REIDENBERG, M
TYBERG, T
LLOYD, V
ELLIS, G
HAYES, J
DRAYER, D
机构：
[1] CORNELL UNIV,COLL MED,DEPT MED,NEW YORK,NY 10021
[2] CORNELL UNIV,COLL MED,DEPT PHARMACOL,NEW YORK,NY 10021
来源：
CLINICAL RESEARCH | 1978年 / 26卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A244 / A244
页数：1
相关论文
共 50 条
[31]   TRIMETHOPRIM INHIBITION OF THE RENAL CLEARANCE OF PROCAINAMIDE AND N-ACETYLPROCAINAMIDE [J].
VLASSES, PH ;
KOSOGLOU, T ;
CHASE, SL ;
GREENSPON, AJ ;
LOTTES, S ;
ANDRESS, E ;
FERGUSON, RK ;
ROCCI, ML .
ARCHIVES OF INTERNAL MEDICINE, 1989, 149 (06) :1350-1353
[32]   COMPARATIVE VAGOLYTIC EFFECTS OF PROCAINAMIDE AND N-ACETYLPROCAINAMIDE IN THE DOG [J].
PEARLE, DL ;
SOUZA, JD ;
GILLIS, RA .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1983, 5 (03) :450-453
[33]   ARRHYTHMIA CONTROL BY SELECTIVE LENGTHENING OF CARDIAC REPOLARIZATION - ROLE OF N-ACETYLPROCAINAMIDE, ACTIVE METABOLITE OF PROCAINAMIDE [J].
SINGH, BN ;
FELD, G ;
NADEMANEE, K .
ANGIOLOGY, 1986, 37 (12) :930-938
[34]   COMPARATIVE EVALUATION OF PROCAINAMIDE AND ITS MAIN METABOLITE, N-ACETYLPROCAINAMIDE, IN ACUTE TREATMENT OF VENTRICULAR ARRHYTHMIAS [J].
KARLSSON, E ;
SONNHAG, C .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 4 (05) :632-632
[35]   CLINICAL PHARMACOKINETICS OF N-ACETYLPROCAINAMIDE [J].
CONNOLLY, SJ ;
KATES, RE .
CLINICAL PHARMACOKINETICS, 1982, 7 (03) :206-220
[36]   EFFECTS OF N-ACETYLPROCAINAMIDE AND PROCAINAMIDE ON MYOCARDIAL CONTRACTILE-FORCE [J].
LERTORA, JJL ;
GLOCK, D ;
STEC, GP ;
ATKINSON, AJ ;
GOLDBERG, LI .
FEDERATION PROCEEDINGS, 1979, 38 (03) :696-696
[37]   SUSTAINED LEVELS OF N-ACETYLPROCAINAMIDE (NAPA) IN RENAL-FAILURE [J].
GIBSON, T ;
MATUSIK, E ;
BRIGGS, W .
KIDNEY INTERNATIONAL, 1975, 8 (06) :425-425
[38]   KINETICS OF N-ACETYLPROCAINAMIDE DEACETYLATION IN MAN [J].
STEC, GP ;
RUO, TI ;
THENOT, JP ;
ATKINSON, AJ ;
MORITA, Y ;
LERTORA, JJL .
CLINICAL RESEARCH, 1980, 28 (04) :A760-A760
[39]   RELATIONSHIP BETWEEN N-ACETYLPROCAINAMIDE (NAPA) SERUM CONCENTRATIONS (SC) AND ORAL PROCAINAMIDE (PA) IN ELDERLY MALE-PATIENTS [J].
FARRINGER, JA ;
JOLLY, MK ;
GARRELTS, JC ;
HARRIS, SC ;
CLEMENTI, WA .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1983, 17 (06) :450-450
[40]   SUSTAINED LEVELS OF N-ACETYLPROCAINAMIDE (NAPA) IN RENAL-FAILURE [J].
GIBSON, T ;
MATUSIK, E ;
BRIGGS, W .
CLINICAL RESEARCH, 1975, 23 (04) :A476-A476
12345